Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-03
1995-03-28
Fay, Zohren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
054017599
ABSTRACT:
The invention relates to a method of enhancing vascularization and growth of neural grafts in warm-blooded animals, especially man, comprising administering an effective amount of the nimodipine, a calcium channel blocker, having the formula 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3-(.beta.-methoxyethy l ester)-5-(isopropyl ester) to the animals to achieve such enhancement and growth. The method enhances the survival rate of transplantations.
REFERENCES:
patent: 4406906 (1983-09-01), Meyer
Gisvold et al. "Drug Therapy In Brain Ischaemia" Br. J. Anaesth, (1985) 57, 96-109.
Dunnett Stephen B.
Finger Stanley
Fay Zohren
Miles Inc.
LandOfFree
Nimodipine enhanced growth and vascularization of neural grafts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nimodipine enhanced growth and vascularization of neural grafts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nimodipine enhanced growth and vascularization of neural grafts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2250853